drugset / Trial / NCT01787110

An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction

NCT01787110

RandomizedParallel-groupOpen-labelTreatment

Summary

The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI) is manifested in international treatment guidelines and established in prehospital and hospital clinical routine throughout the world. However, to date there is no conclusive evidence from adequately designed and powered trials supporting this practice. Existing data is conflicting and failing to clarify the role of supplemental oxygen in AMI. The DETO2X-AMI trial is designed to shed light on this important issue.

Timeline

Start
2013-04
Primary completion
2016-12-30
Completion
2016-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxygen Other / unclassified 6000 ml Other